CEBINA uniquely supports life science entrepreneurs and early-stage start-up companies and develops cutting-edge biotech projects


CEBINA was founded with the aim of creating, nurturing, and promoting early-stage life sciences companies, to develop new medicines and cutting-edge technologies.


With decades-long experience in pharmaceutical product development and biotech entrepreneurship, our team supports our internal projects and resident companies with cutting edge facilities and tailor-made services throughout all stages of company development.


For each new project, CEBINA undertakes extensive due diligence to identify projects with the highest potential, offering attractive, de-risked opportunities for investors.

DL square for CEBINA website.png

19 April 2021

Danube Labs: Call for Proposals

Read more

EVQ green square.png

23 February 2022

Eveliqure announces the publication of positive Phase I clinical data for its vaccine candidate against Shigellosis and ETEC

Read more

CEBINA covid square.png

03 February 2022

Azelastine - the active drug in anti-allergy nasal sprays demonstrated to have potent anti-viral effect on the Omicron variant of

Read more


Karl-Farkas-Gasse 22

1030 Vienna, Austria